PharmaCyte Biotech, Inc.

New Filing

CIK: 0001157075·Biotechnology·NEVADA·Filed: Sep 4, 2025

Total Offering

$7,000,000

Amount Sold

$7,000,000

Investors

12

First Sale

Aug 17, 2025

Offering Details

Type: Equity, Option to Acquire
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Joshua N. Silverman	Related Person
Carlos Trujillo	Related Person
Michael M. Abecassis	Related Person
Robert Weinstein	Related Person
Walker R. Wayne	Related Person
Jonathan L. Schechter	Related Person

Company

PharmaCyte Biotech, Inc.

3960 HOWARD HUGHES PARKWAY

LAS VEGAS, NV, 89169

(917) 595.2850

SEC Filing

0001683168-25-006676

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.